CoChat

The Value of Small Observations in the Era of Big Science

Open access
Gruber, Stephen B. · 2005 · Cancer Epidemiology, Biomarkers & Prevention
Cited by 98

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

We are now unequivocally in the era of big science. Genotyping costs have become so trivial and genetic variation is so important that it is almost heresy to consider launching an epidemiologic investigation without collecting germ line DNA to evaluate the contributions of genetic diversity to the pathogenesis of disease. As genetics steps into the spotlight of epidemiology, studies are bursting in size (and cost) to evaluate interactions of genes and the environment and to precisely measure the magnitude of small associations. Technology has given us epidemiology on steroids. This big science approach has evolved as a consistent research strategy even for cancers where the environmental contributions are unequivocal and dominant. Smoking causes lung cancer, human papillomavirus causes cervical cancer, and excessive UV exposure causes melanoma, but, of course, the story is a bit more complicated. There is no question that we need to learn more about the causal pathways exploited by these carcinogens and how they can be modified even when epidemiology has successfully elucidated the main causes of disease. The real question is, is there still room for small science?An example of the kind of insight that can be gained from small science is published in a recent issue of Cancer Epidemiology Biomarkers and Prevention. The study of MC1R variants and the risk of melanoma by Goldstein et al. (1) examined 16 families with melanoma that carry mutations of CDKN2A. In this study, we learn that the presence of multiple MC1R variants is associated with the risk of melanoma and that these variants contribute to the clinical presentation of patients with multiple primary melanoma. Some might argue that a study of 395 individuals is not small, but perhaps what best captures the idea of small science is the reliance on an extremely well-characterized phenotype and thoughtful comparisons that yield insight. In the Goldstein study, clinical and epidemiologic data collected over 26 years provide a unique resource to measure the genetic and environmental contributions to multiple primary melanoma, specifically in melanoma-prone families who carry a mutation in CDKN2A. This study is a wafer-thin slice of a very big pie.Yet, it is precisely the care in choosing the thin slice that can provide generalizable insight. Numerous studies have shown a relationship between MC1R and the risk of melanoma (2-4) and two studies have shown that the presence of an MC1R variant increases the penetrance of CDKN2A mutation carriers (5, 6). Other studies have shown that carrying multiple variants is associated with more risk than a single variant (7). Here, as in prior studies, the relative risk for MC1R was stronger for those variants designated as red hair color compared with non–red hair color variants, and the risk seemed cumulative with additional variants. In addition, by focusing on a comparison of multiple primary versus single primary melanoma, the authors showed that MC1R is a risk factor for multiple primary melanoma and that cumulative mutations are associated with decreasing age at diagnosis, beyond the effects of a major gene like CDKN2A. This approach is another good example of how studies that concentrate on comparisons of multiple primary and single primary cancers can provide an informed perspective on risk factors from a different vantage point (8).Phenotype is the key to small science, and perhaps the best example is Knudson's classic study of retinoblastoma (9). By recognizing the unique phenotype of children with young-onset, bilateral, familial retinoblastoma, Knudson's work led to the “two-hit” hypothesis and the eventual discovery of the first tumor suppressor gene. It is worthwhile to remind ourselves that the sample size of Knudson's study was only 48 children (9). Similarly, the success in identifying DES as the cause of clear cell adenocarcinoma of the vagina relied on focusing on an extremely rare pathologic phenotype. The original case-control study by Herbst et al. (10) included a grand total of 8 cases and 32 controls.Epidemiology will continue to rely on carefully defined phenotypes and this will require more than our reflexive reliance on “pathologically confirmed diagnoses” as the hallmark of well-designed cancer studies to minimize the possibility of misclassification of disease. Technology is once again providing us with the muscle to define phenotypes more clearly, and it is likely that molecular classification of tumors will play an even more prominent role in the future of cancer epidemiology.Goldstein et al.'s article also serves as an example of how one can intelligently examine phenotype to gain perspective on the contributions of multiple genes. Indeed, the term “gene-gene interaction” is not used consistently in genetic research. Does this only refer to biochemical evidence of protein binding or direct modulation of a downstream effect by multiple DNA variants? Or could it refer to multiple genes that

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1055-9965.epi-05-0321

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 98

Metadata

Authors
Gruber, S. B.
Venue
Cancer Epidemiology, Biomarkers & Prevention
Published
2005-11-01
Volume
14
Issue
11
Pages
2472-2473
ISSN
  • 1055-9965 (ISSN-L)
  • 1538-7755
OpenAlex
W2184781233
Cited by
98
References
2
FWCI
4.20
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Value of Small Observations in the Era of Big Science. https://app.cochat.ai/papers/10.1158/1055-9965.epi-05-0321
The paper
Gruber, S. B. (2005). The Value of Small Observations in the Era of Big Science. Cancer Epidemiology, Biomarkers & Prevention. https://doi.org/10.1158/1055-9965.epi-05-0321

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.